Answers are grounded in this paper and cite their sources.
Health-related quality of life (HRQoL) is a predictor of treatment outcomes in cancer patients. This study aimed to evaluate the effect of pretreatment HRQoL on treatment tolerance and survival outcomes in patients with HNC planned for concurrent chemoradiotherapy (CCRT) in Taiwan.
No takes yet. Share an insight, caveat, or question.
Hung et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: